Skip to main content
Swiss Re AG logo

Swiss Re AG — Investor Relations & Filings

Ticker · SREN ISIN · CH0126881561 LEI · 529900PS9YW3YY29F326 SW Financial and insurance activities
Open in API
Filings indexed 325 across all filing types
Latest filing 2025-09-17 Regulatory Filings
Country CH Switzerland
Listing SW SREN

About Swiss Re AG

https://www.swissre.com/

Swiss Re AG is a leading wholesale provider of reinsurance, insurance, and other insurance-based forms of risk transfer. The company's core business is structured into several segments, including Property & Casualty Reinsurance, Life & Health Reinsurance, and Commercial Insurance solutions for corporate clients. It also offers Risk Data Solutions to help insurers, corporations, and governments navigate complex risks with greater precision. By absorbing significant risks, from natural catastrophes and climate change to pandemics and cybercrime, the company aims to make the world more resilient, enabling its clients and society to thrive and progress.

Recent filings

Filing Released Lang Actions
GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045
Regulatory Filings Classification · 100% confidence The document is a press release from Swiss Re announcing the publication of a research study titled 'The future of metabolic health and weight loss drugs'. It provides a summary of the findings, quotes from executives, and includes a link to the full report on the company's website. Per the 'Menu vs Meal' rule, since this is a short announcement directing the reader to an external report, it is classified as a Report Publication Announcement (RPA).
2025-09-17 English
GLP-1 drugs may reduce mortality by up to 6.4% in the US by 2045
Regulatory Filings Classification · 100% confidence The document is a press release from Swiss Re announcing the publication of a research study regarding the impact of GLP-1 drugs on mortality rates. It provides a summary of the findings and includes a link to the full study on the company's website. According to the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-09-17 English
GLP 1-Medikamente könnten Sterblichkeit in den USA bis 2045 um bis zu 6,4% senken
Regulatory Filings Classification · 100% confidence The document is a press release from Swiss Re announcing the publication of a research study titled 'The future of metabolic health and weight loss drugs'. It provides a summary of the study's findings regarding GLP-1 medications and their impact on mortality, but explicitly directs the reader to an external link on the company's website to access the full report. Following the 'Menu vs Meal' rule, since this is a short announcement (under 5,000 characters of core content) that directs the user to an external report, it is classified as a Report Publication Announcement (RPA).
2025-09-17 German
Holistic approach needed to maintain resilience in a complex risk landscape
Regulatory Filings Classification · 100% confidence The document is a press release issued by Swiss Re regarding their participation in the 'Rendez-Vous de Septembre' conference. It discusses industry themes such as geopolitical risk, natural catastrophe losses, and the role of AI in insurance. It does not contain financial statements, audit results, or regulatory filings, but rather serves as a corporate communication/announcement regarding industry outlook and media events. As it does not fit into specific categories like 10-K, IR, or ER, and is a general corporate announcement, it is classified as a Regulatory Filing (RNS).
2025-09-08 English
Holistic approach needed to maintain resilience in a complex risk landscape
Regulatory Filings Classification · 100% confidence The document is a press release issued by Swiss Re regarding their outlook on the re/insurance market ahead of the 'Rendez-Vous de Septembre' conference. It discusses industry themes such as geopolitical risks, natural catastrophe losses, and the role of AI. It does not contain financial statements, audit results, or specific regulatory filings, but rather serves as a general corporate communication/news update. Under the provided definitions, general regulatory announcements and miscellaneous filings that do not fit specific categories are classified as RNS.
2025-09-08 English
Ganzheitlicher Ansatz erforderlich, um Widerstandsfähigkeit trotz komplexer Risiken beizubehalten
Regulatory Filings Classification · 100% confidence The document is a press release issued by Swiss Re regarding their participation in the 'Rendez-Vous de Septembre' in Monte Carlo. It discusses industry trends such as natural catastrophe risks, geopolitical uncertainty, and the role of AI in insurance. It does not contain financial statements, audit results, or specific regulatory filings, but rather serves as a corporate communication/announcement regarding the company's outlook and upcoming media conference. As it is a general regulatory announcement that does not fit into more specific categories like earnings releases or reports, it is classified as a Regulatory Filing (RNS).
2025-09-08 German

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.